FDA approves ArkBio’s ziresovir for Phase II trial in severe RSV Clinical Trials Arena 10:57 Mon, 17 Aug
ArkBio's Rsv Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial PR Newswire (Press Release) 11:10 Fri, 14 Aug
ArkBio Announces China Ind Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis PR Newswire (Press Release) 02:03 Thu, 13 Aug
Moderna and Merck’s Personalized mRNA Cancer Vaccine Succeeds in Landmark Phase 3 Melanoma Trial The Red Ferret Journal 4d Moderna Vaccine mRNA Global Health All sources
Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe? The Economic Times 1d Symbiotec Pharmalab All sources
Skyclarys approved: HSE to fund Friedreich’s Ataxia drug for Irish patients JOE.ie 16h Skyclarys Rep. of Ireland All sources
Werewolf Therapeutics (HOWL) stock is trending overnight—here's why it jumped 90% after hours Benzinga 5d Article paywall All sources
